News Views and the Muse: Peru Ivermectin Study

Photo by Max Rue

The Peru Study

On August 8, 2023, an absolute bombshell ivermectin study from Peru was published in the Cureus Journal of Medical Science, by a Ph.D., an Sc.D., and a data analyst.   As far as I can tell, virtually nobody has so far noticed. This study, beautifully written up –read it—

https://www.cureus.com/articles/172991-covid-19-excess-deaths-in-perus-25-states-in-2020-nationwide-trends-confounding-factors-and-correlations-with-the-extent-of-ivermectin-treatment-by-state?fbclid=IwAR01Zic9VRHWUSSk9_Llo3AQ64O2qV9YGOKv4ogicVWtqyfRXH3MuX1sf7k#!/

…provides incontrovertible evidence that large-scale use of ivermectin can save whole populations from the ravages of pandemics like Covid-19.  Or rather, could have saved whole populations from the ravages if it had been used.  I am going to discuss this study in detail to show you why this this is true.

Before I get started, though, I want to mention two important things:

1.     So far, the current circulating Covid variants, including this new Eris variant, EG-5, seem to be causing such mild symptoms that they are virtually indistinguishable from common colds.  Hardly anybody needs ivermectin or other special treatment any more for such a mild disease, though some vulnerable people do get very sick from colds, and in those cases, ivermectin would likely be helpful and is worth taking.  Unfortunately, we now have a very large population of very vulnerable people whose immune systems have been weakened by multiple Covid shots and boosters—most Covid deaths are now in those populations.  If you are one of those vulnerable people, it might be quite worth your while to stock up on things like ivermectin, and to obtain the other medications and supplements as recommended by the FLCCC Alliance, link here:  https://covid19criticalcare.com/treatment-protocols/

2.     Ivermectin is very likely an effective treatment for other viruses, including seasonal flu and RSV…and has a very good chance of being effective for whatever new “pandemic” comes along.  Looking carefully at this Peruvian study is not just for historical purposes, but should be a go-to for WHATEVER public infectious disease emergency comes down the pike.

(I plan to devote more space to this item in a future post.)

…………………………………………………………………………………………..

The Peru Study

From the study write-up: 

“As one therapeutic option, on May 8, 2020, the Peruvian Ministry of Health approved treatment using ivermectin (IVM)”

“In each targeted locality, operation Mega Operacion Tayta  {MOT}   began with outreaches, including home visits, by local officials to identify people at highest risk for COVID-19 mortality, due to either age or other vulnerabilities [35]. No IVM was distributed through MOT during this preparatory period, but it was freely available everywhere in Peru without a prescription, and people identified as vulnerable had the capability to purchase and take it during that time on their own initiative. A week later, field workers from MOT then began the distribution of IVM to everyone identified as being at risk, whether or not they tested positive or were symptomatic for COVID-19 [35]. Other drugs commonly distributed along with IVM were acetaminophen and azithromycin [10,36]. “

Rapid response teams, including members of personnel from the Army, Navy, Air Force, and police, partnering with local health officials, manned the effort.

“The level of popular interest in IVM treatments for COVID-19, as spurred by these reports, was so high that it led to IVM shortages in Peruvian pharmacies [21], which motivated smugglers [22] and counterfeiters [23] to cover the demand.”

The doses of ivermectin that government teams gave people were tiny: 

“The typical dose of IVM provided to both COVID-19 inpatients and outpatients was 200 µg/kg for a single day for mild cases, repeated a second day for more serious cases “

That dose is .2 milligrams per kilogram, for one or two days.  During 2020, FLCCC (see link above) recommended .2 mg/kg twice a week for prevention, and .4 mg to .6 mg per kilogram daily for 5 days for early active cases.

…………………………………………………………………

Result? 

“….the mean reductions in excess deaths 30 days after date of peak deaths were 74%, 53%, and 25% for the maximal, medium, and minimal IVM distribution states, respectively. Figure 2C shows these drops in excess deaths over 30 days for the 25 states, by tier of IVM distribution. At 45 days after peak deaths, these mean reductions were 86%, 70%, and 25%, respectively. For nine of the 10 MOT states (excluding Pasco, which had three IVM distribution dates), MOT start dates were plotted together with dates of peak deaths in Figure 2B. As shown there, excess deaths dropped sharply in close time conjunction with the MOT start dates.”

But then,

“….on November 17, 2020, a new president of Peru, Francisco Sagasti, took office [7]. Government distributions of IVM, the channel by which most patients had obtained it previously, were then stopped, with its further use allowed only by a doctor’s prescription [8-12].”

What happened then?

Excess all-cause deaths (all ages), national population of Peru.

The graph above shows all you need to know.

Details are explained very nicely in the actual study write-up.

……………………………………………………………………………………….

The evidence shows, incontrovertibly, Ivermectin works.  Fabulously. Millions of lives could have been saved if this old, safe, previously-acclaimed drug had been used worldwide as it was used for those short months in Peru.